Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Chin J Nat Med ; 16(6): 471-480, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-30047469

RESUMO

The therapeutic application of deoxypodophyllotoxin (DPT) is limited due to its poor water solubility and stability. In the present study, the micelles assembled by the amphiphilic block copolymers (mPEG-PDLLA) were constructed to improve the solubility and safety of DPT for their in vitro and in vivo application. The central composite design was utilized to develop the optimal formulation composed of 1221.41 mg mPEG-PDLLA, the weight ratio of 1 : 4 (mPEG-PDLLA : DPT), 30 mL hydration volume and the hydration temperature at 40 °C. The results showed that the micelles exhibited uniformly spherical shape with the diameter of 20 nm. The drug-loading and entrapment efficiency of deoxypodophyllotoxin-polymeric micelles (DPT-PM) were about (20 ± 2.84)% and (98 ± 0.79)%, respectively, indicating that the mathematical models predicted well for the results. Compared to the free DPT, the cytotoxicity showed that blank micelles possessed great safety for Hela cells. In addition, the DPT loaded micelle formulation achieved stronger cytotoxicity at the concentration of 1 × 10-7 mol·L-1, which showed significant difference from free DPT (P < 0.05). In conclusion, the micelles were highly promising nano-carriers for the anti-tumor therapy with DPT.


Assuntos
Portadores de Fármacos/química , Sistemas de Liberação de Medicamentos/métodos , Desenho de Fármacos , Micelas , Podofilotoxina/análogos & derivados , Poliésteres/química , Polietilenoglicóis/química , Antineoplásicos/química , Antineoplásicos/toxicidade , Sobrevivência Celular/efeitos dos fármacos , Medicamentos de Ervas Chinesas , Células HeLa , Humanos , Tamanho da Partícula , Podofilotoxina/química , Podofilotoxina/toxicidade , Solubilidade , Propriedades de Superfície
2.
Zhongguo Zhong Yao Za Zhi ; 42(7): 1401-1406, 2017 Apr.
Artigo em Chinês | MEDLINE | ID: mdl-29052406

RESUMO

In this paper, the status of adjuvant standard for Chinese materia medica processing in the Chinese Pharmacopoeia 2015 edition, the National Specification of Chinese Materia Medica Processing, and the 29 provincial specification of Chinese materia medica was summarized, and the the status including general requirements, specific requirements, and quality standard in the three grade official specifications was collected and analyzed according to the "medicine-adjuvant homology" and "food-adjuvant homology" features of adjuvants. This paper also introduced the research situation of adjuvant standard for Chinese materia medica processing in China; In addition, analyzed and discussed the problems existing in the standard system of adjuvant for Chinese materia medica processing, such as lack of general requirements, low level of standard, inconsistent standard references, and lack of research on the standard, and provided suggestions for the further establishment of the national standards system of adjuvant for Chinese materia medica processing.


Assuntos
Adjuvantes Farmacêuticos/normas , Materia Medica/normas , Medicina Tradicional Chinesa/normas , China
3.
Drug Deliv ; 19(4): 232-7, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22643057

RESUMO

To administer indomethacin (IND) orally using polymeric micelles, IND loaded solidified polymeric micelles (IND-SPM) were prepared and evaluated for their in vitro and in vivo characteristics. IND and methoxy-poly(ethylene glycol) poly(d, l-lactide) copolymer (mPEG-PDLLA) were dissolved in acetone followed by the addition of an equivalent amount of polyplasdone XL-10 and stirred to obtain a suspension. Afterwards, acetone was completely evaporated. It was found that IND-SPM generates small polymeric micelles of 18.1 nm. Moreover, the solubility of IND at pH 6.8 increased 4.6-folds, and more than 90% of IND in 20 mg of IND-SPM was dissolved in 250 mL SIF pH 6.8 within 30 min. Pharmacokinetic parameters in fasted rats showed that IND-SPM 1:3 resulted in 3-folds increase of AUC and C(max) compared to commercial IND. mPEG-PDLLA micelles were found to be efficient carriers for oral administration of IND as solid dosage forms by adsorption on polyplasdone XL-10.


Assuntos
Sistemas de Liberação de Medicamentos/métodos , Indometacina/administração & dosagem , Micelas , Poliésteres/administração & dosagem , Polietilenoglicóis/administração & dosagem , Administração Oral , Animais , Indometacina/química , Masculino , Poliésteres/química , Polietilenoglicóis/química , Ratos , Ratos Sprague-Dawley
4.
Yao Xue Xue Bao ; 46(7): 852-8, 2011 Jul.
Artigo em Chinês | MEDLINE | ID: mdl-22010357

RESUMO

This study is to prepare the in situ forming sustained-release injection which can perform sustained release behavior at the periodontal site for 7 days and to evaluate its in vitro and in vivo properties. After preparation of in situ forming sustained-release injection the in situ time was studied. And the surface of the solid injection was characterized by SEM. The rheological curve at 0 degrees C, 25 degrees C, 37 degrees C was determined and the impact of the temperature on the viscosity was examined. The in vitro release behavior was investigated. At last, rabbit periodontitis model was established to study its pharmacokinetics. The injection was stable, hard to stratify and decompose. The in situ forming time was about 6 seconds. It can easily adhere into periodontal pockets. There were lots of holes on the surface of the solid injection for the drug to diffuse. The drug releasing curves could be fit by Korsmeyer-Peppas equation. The drug smoothly released for 7 days at pH 7.4 PBS buffer with a very slight burst release and maintained a certain concentration. In vivo pharmacokinetics results indicated that after administration with the in situ forming injection, achievement of tinidazole (TNZ) concentration in gingival crevicular fluid (GCF) was more comparable and long-lasting than usual solution of TNZ management and relatively constant TNZ levels were attained until 168 h. All these results supported the prospect of tinidazole in situ forming sustained-release injection in clinical applications.


Assuntos
Periodontite/metabolismo , Poliésteres/síntese química , Poliésteres/farmacocinética , Polietilenoglicóis/síntese química , Polietilenoglicóis/farmacocinética , Tinidazol/administração & dosagem , Tinidazol/farmacocinética , Animais , Antitricômonas/administração & dosagem , Antitricômonas/farmacocinética , Preparações de Ação Retardada , Portadores de Fármacos , Composição de Medicamentos/métodos , Endotoxinas , Líquido do Sulco Gengival/metabolismo , Injeções , Bolsa Periodontal/metabolismo , Periodontite/induzido quimicamente , Coelhos , Distribuição Aleatória , Reologia
5.
Yao Xue Xue Bao ; 46(8): 997-1003, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22007527

RESUMO

In this study, indomethacin (IND) loaded solidified-polymeric micelles (IND-SPM) were prepared. Their in vitro characteristics were investigated. Methoxy-poly(ethylene glycol) poly(D, L-lactide) copolymer (mPEG-PDLLA) was used as IND carrier. The preparation of IND-SPM was conducted by solution-absorption method and evaporation by rotary evaporator. Polyplasdone XL-10 was used as adsorbent. The solution-absorption method was conducted by the following procedure; IND and mPEG-PDLLA were dissolved in acetone, followed by addition of polyplasdone XL-10 and stirred to obtain a suspension. The powder of IND-SPM was simply obtained after the organic solvent was completely evaporated. More than 90% (w/w) of IND (20 mg) in the powder was dissolved in 250 mL PBS within 30 min. DSC, 1H NMR and SEM results proved that IND was encapsulated within mPEG-PDLLA. The solubility of IND in the system increased 4.6 times with the highest amount of copolymer. The solidified particles were found to be suitable for the formulation of tablets or capsules.


Assuntos
Anti-Inflamatórios não Esteroides/administração & dosagem , Sistemas de Liberação de Medicamentos , Indometacina/administração & dosagem , Poliésteres/química , Polietilenoglicóis/química , Administração Oral , Anti-Inflamatórios não Esteroides/química , Portadores de Fármacos/química , Composição de Medicamentos , Indometacina/química , Micelas , Povidona/química , Solubilidade
6.
J Zhejiang Univ Sci B ; 10(12): 877-82, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19946951

RESUMO

A high-performance liquid chromatography (HPLC) system was used in the reversed phase mode for the determination of benzalkonium chloride (BKC) in azithromycin viscous ophthalmic drops. A Venusil-XBP(L)-C(18) (150 mmx4.6 mm, 5 microm) column was used at 50 degrees C. The mobile phase consisted of a mixture of methanol-potassium phosphate (16:5, v/v). Two sample preparation methods were compared. The results suggested that, compared with an extraction procedure, a deproteinization procedure was much quicker and more convenient. Using the deproteinization procedure for sample preparation, calibration curves were linear in the range 5.0 to approximately 50 microg/ml. The within-day and inter-day coefficients of variation were less than 10%. The average recoveries were determined as 96.70%, 98.52%, and 97.96% at concentrations of 10.0, 30.0, and 50.0 microg/ml, respectively. Variability in precision did not exceed 5%. In conclusion, this HPLC method using a simple sample treatment procedure appears suitable for monitoring BKC content in azithromycin viscous ophthalmic drops.


Assuntos
Azitromicina/análise , Compostos de Benzalcônio/química , Técnicas de Química Analítica/métodos , Cromatografia Líquida de Alta Pressão/métodos , Soluções Oftálmicas/química , Calibragem , Cromatografia/métodos , Modelos Químicos , Reprodutibilidade dos Testes , Viscosidade
7.
Yao Xue Xue Bao ; 44(4): 430-5, 2009 Apr.
Artigo em Chinês | MEDLINE | ID: mdl-19545064

RESUMO

To develop different methods for determining siRNA content and the entrapment efficiency of siRNA loaded liposomes, SYBR Gold electrophoresis method and Ribogreen fluorospectrophotometry method were used respectively. SYBR Gold electrophoresis method has a good linear relation in a range at 0.2-2.0 micromol x L(-1) (R = 0.9930), and the recovery at the high, middle and low concentrations were 96.35%, 96.92%, and 100.74%, respectively (n = 3). The intra-day and inter-day RSD were far below 5% (n = 5). Ribogreen fluorospectrophotometry method has a good linear relation in a range at 10-50 nmol x L(-1) (R = 0.9971), and the recovery at the high, middle and low concentrations were 98.22%, 99.88% and 99.64%, respectively (n = 3). The intra-day and inter-day RSD were far below 5% (n = 5). The content and the entrapment efficiency of three batches of siRNA cationic liposomes were 98.52%, 97.85% and 99.20%, 96.45%, respectively, with these two methods. And there is no significant difference by ANOVA. Both of the two methods are accurate, sensitive, convenient method for determination of the siRNA content and the entrapment efficiency of siRNA loaded cationic liposomes.


Assuntos
Sistemas de Liberação de Medicamentos , Lipossomos/química , RNA Interferente Pequeno/análise , Portadores de Fármacos , Eletroforese , Espectrometria de Fluorescência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...